Key points are not available for this paper at this time.
Our study identified the biological role of the circROBO1-miR-556-5p-PGK1 axis in the growth and enzalutamide resistance of prostate cancer, which is the potential therapeutic target of prostate cancer.
Zhou et al. (Sun,) studied this question.